Amgen (AMGN) Tops Q4 EPS by 27c, Beats on Revenue; Offers FY25 EPS Guidance
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $415.21 -0.63%
Financial Fact:
Total operating expenses: 3.28B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total operating expenses: 3.28B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q4 EPS of $5.31, $0.27 better than the analyst estimate of $5.04. Revenue for the quarter came in at $9.1 billion versus the consensus estimate of $8.85 billion.
GUIDANCE:
Amgen sees FY2025 EPS of $20.00-$21.20, versus the consensus of $20.82.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Phillips 66, Marathon Merger Talks Collapsed - Semafor
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
